throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LIMITED,
`ALEMBIC PHARMACEUTICALS LIMITED, TORRENT
`PHARMACEUTICALS LIMITED, AND AMERIGEN PHARMACEUTICALS
`LIMITED
`
`Petitioner,
`
`v.
`
`UCB PHARMA GMBH
`
`Patent Owner.
`
`Patent No. 6,858,650
`Case IPR2016-00510
`
`
`
`
`PETITIONER MYLAN PHARMACEUTICALS INC. AND MYLAN
`LABORATORIES LIMITED’S RESPONSE TO PAPER NO. 41
`REGARDING LEAD COUNSEL AND ARGUMENT
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`
`
`Petitioner Mylan Pharmaceuticals Inc. and Mylan Laboratories Limited
`
`(jointly “Mylan”)1 submits the following in Response to the Board’s Inquiry
`
`regarding lead counsel and oral argument. Paper 41. On Friday, March 31, 2017,
`
`Back-Up Counsel Clay Holloway submitted copies of the demonstratives in the
`
`five IPRs set for hearing on April 5, 2017. Mr. Holloway also informed the Board
`
`that Lead Counsel, Mitchell Stockwell, would be unable to attend the hearing.
`
`Given the deadline for initiating a conference regarding whether Lead Counsel
`
`would be able to attend the hearing was set for today, April 3, 2017, Mr. Holloway
`
`intended Friday’s notice to comply with that requirement. A request for a phone
`
`conference should have been made, and Petitioner apologizes for that oversight.
`
`If the Board desires a phone conference in advance of the April 5 hearing,
`
`counsel for Petitioner is available at any time and will make all necessary
`
`arrangements for that conference call.
`
`In response to the Board’s questions, Petitioner submits the following:
`
`a) Until March 24, 2017, Mr. Stockwell, Lead Counsel, planned to
`
`accompany Mr. Holloway, who would present argument on behalf of Petitioner, to
`
`the April 5 hearing. On March 24, 2017, Mr. Stockwell learned that his daughter
`
`
`1 Petitioner Alembic Pharmaceuticals Limited from IPR2016-01596, Torrent
`Pharmaceuticals Limited from IPR2016-01636, and Amerigen Pharmaceuticals
`Limited from IPR2016-01665 have been joined as Petitioner to this proceedings.
`
`1
`
`
`
`

`

`had been selected and invited to participate in a competitive gymnastics event that
`
`would require him to again travel on the eve of his April 1 return from depositions
`
`in Ireland. Her invitation and participation in the competition scheduled for the
`
`week of April 3, while a possibility, was an unforeseen addition to Mr. Stockwell’s
`
`calendar.
`
`b) As the Board’s Trial Hearing Order permits any counsel of record to
`
`make the hearing argument (Paper 38, 4), and the plan was for Mr. Holloway to
`
`argue and Mr. Stockwell to attend the hearing, Petitioner did not foresee the need
`
`to switch Lead Counsel designation from Mr. Stockwell to Mr. Holloway. If this
`
`change is preferred by the Board, Petitioner does not object to the replacement of
`
`Mr. Stockwell with Mr. Holloway. As noted in Paper No. 41, Mr. Holloway has
`
`been involved in this case since the preparation and filing of the petitions, through
`
`the replies, and associated filings, and has worked alongside Mr. Stockwell in the
`
`related district court litigation.
`
`Again, Petitioner respectfully apologizes for any inconvenience in the
`
`manner in which Petitioner brought this matter to the Board’s attention.
`
`2
`
`
`
`
`Date: April 3, 2017
`
`
`
`
`

`

`Back-Up Counsel
`D. Clay Holloway
`Reg. No. 58,011
`cholloway@kilpatricktownsend.com
`Kilpatrick Townsend & Stockton LLP
`1100 Peachtree Street, NE
`Suite 2800
`Atlanta, Georgia 30309
`(404) 815 6500
`
`Alyson L. Wooten
`Reg. No. 58,045
`awooten@kilpatricktownsend.com
`Kilpatrick Townsend & Stockton LLP
`1100 Peachtree Street, NE
`Suite 2800
`Atlanta, Georgia 30309
`(404) 815 6500
`
`3
`
`By: /s/ Mitchell G. Stockwell
`Mitchell G. Stockwell
`Registration No. 39,389
`Lead Counsel for Petitioner
`
`
`Lead Counsel
`Mitchell G. Stockwell
`Reg. No. 39,389
`mstockwell@kilpatricktownsend.com
`Kilpatrick Townsend & Stockton
`LLP
`1100 Peachtree Street, NE
`Suite 2800
`Atlanta, Georgia 30309
`(404) 815 6500
`
`
`
`
`
`

`

`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of PETITIONER MYLAN
`
`PHARMACEUTICALS INC. AND MYLAN LABORATORIES LIMITED’S
`
`RESPONSE TO PAPER NO. 41 REGARDING LEAD COUNSEL AND
`
`ARGUMENT was served on April 3, 2017, by filing this document through the
`
`Patent Trial and Appeal Board End to End system, as well as delivering a copy via
`
`electronic mail upon the following attorneys of record:
`
`Jeffrey Ginsberg
`Kenyon & Kenyon LLP
`One Broadway
`New York, New York 10004-1007
`
`with a courtesy copy to counsel for Pfizer Inc. and UCB Pharma GMBH, Plaintiffs
`
`in the underlying litigation as follows:
`
`Jack Blumenfeld
`Morris, Nichols, Arsht & Tunnell LLP
`1201 North Market Street
`Wilmington DE 19899
`Dimitrios T. Drivas
`Jeffrey J. Oelke
`James S. Trainor, Jr.
`Ryan P. Johnson
`Robert Counihan
`WHITE &CASE LLP
`1155 Avenue of the Americas
`New York, NY 10036
`
`By: /s/ Mitchell G. Stockwell
`Registration No. 39,389
`Counsel for Petitioner
`
`
`
`
`Dated: April 3, 2017
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket